Prediction of prognosis regarding fractionation schedule and survival in patients with whole-brain radiotherapy for metastatic disease

Anticancer Research

Volumn 28, Issue 6 B, 2008, Pages 3965-3969

  Meyer, Andreas ^a   Steinmann, Diana ^a   Malaimare, Liliana ^a   Karstens, Johann H ^a   Bremer, Michael ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Brain metastases; Palliative radiotherapy; Survival prediction; Whole brain radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FRACTIONATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; WHOLE BRAIN RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; BREAST NEOPLASMS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 58149158188     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chow E, Fung K, Panzarella T, Bezjak A, Danjoux C and Tannock I: A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic. Int J Radiat Oncol Biol Phys 53: 1291-1302, 2002.
2. Chow E, Davis L, Panzarella T, Hayter C, Szumacher E, Loblaw A, Wong R and Danjoux C: Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys 61: 870-873, 2005.
3. Rades D, Raabe A, Bajrovic A and Alberti W: Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site. Strahlenther Onkol 180: 144-147, 2004.
4. Gaspar LE, Scott C, Rotman M, Asbell S, Phillips T and Wasserman T: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745-751, 1997.
5. Fleckenstein K, Hof H, Lohr F, Wenz F and Wannenmacher M: Prognostic factors for brain metastases after whole-brain radiotherapy. Data from a single institution. Strahlenther Onkol 180: 268-273, 2004.
6. Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E and Laperriere N: Whole-brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 3: 1-57, 2006.
7. Rades D, Kieckebusch S, Lohynska R, Veninga T, Stalpers LJ, Dunst J and Schild SE: Reduction of overall treatment time in patients irradiated for more than three brain metastases. Int J Radiat Oncol Biol Phys 69: 1509-1513, 2007.
8. Gripp S, Moeller S, Bölke E, Schmitt G, Matuschek C, Asgari S, Asgharzadeh F, Roth S, Budach W, Franz M and Willers R: Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 25: 3313-3320, 2007.
9. Lutterbach J, Bartelt S and Ostertag C: Long-term survival in patients with brain metastases. J Cancer Res Clin Oncol 128: 417-425, 2002.
10. Chao ST, Barnett GH, Liu SW, Reuther AM, Toms SA, Vogelbaum MA, Videtic GM and Suh JH: Five-year survivors of brain metastases: a single-institution report of 32 patients. Int J Radiat Oncol Biol Phys 66: 801-809, 2006.
11. Christakis NA and Lamont EB: Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ 320: 469-474, 2000.
12. Chow E, Harth T, Hruby G, Finkelstein J, Wu J and Danjoux C: How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol) 13: 209-218, 2001.
13. Johansen R, Westin AA, Bofin AM and Lundgren S: Outcome of whole-brain irradiation for breast cancer patients. Acta Oncol 47: 261-266, 2008.
14. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP and Curran WJ Jr: Whole-brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665-1672, 2004.
15. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R and Grabenbauer G: Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 81: 18-24, 2006.
16. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N and Kobashi G: Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483-2491, 2006.
17. Nieder C and Grosu AL: Stereotaktische Radiochirurgie von Hirnmetastasen - routinemäßig mit Ganzhirnbestrahlung? Strahlenther Onkol 183: 52-53, 2007.
18. Nieder C, Astner ST, Grosu AL and Molls M: Evaluation of late neurological adverse events in patients with brain metastases from non-small cell lung cancer. Anticancer Res 27: 1701-1704, 2007.
19. DeAngelis LM, Delattre JY and Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 39: 789-796, 1989.
20. Khuntia D, Brown P, Li J and Mehta MP: Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24: 1295-1304, 2006.
21. Kocher M, Eich HT, Semrau R, Güner SA and Müller RP: Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases. Strahlenther Onkol 181: 20-25, 2005.